Back

The Drug-Induced Respiratory Disease Website and App

I.bc

I - Interstitial/parenchymal lung disease

Progression or exacerbation of preexisting/underlying rheumatoid arthritis-associated ILD

Last update 02/09/2026

Can be fatal

Causative drugs

2

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

COVID19 (SARS-CoV2) vaccination/vaccine
I.a
I.b
I.c
I.y
I.ad
I.ay
I.bc
II.b
II.d
III.a
III.m
IV.a
IV.ac
VI.a
VI.b
VI.ac
IX.r
IX.y
IX.ab
X.b
X.d
X.f
X.h
X.j
X.m
X.s
X.aj
X.be
X.bf
X.bg
X.bh
X.bj
XI.b
XII.a
XII.c
XII.d
XII.e
XII.g
XII.h
XII.k
XII.l
XII.m
XII.q
XII.ai
XII.bf
XII.cc
XV.a
XV.c
XVI.b
XVI.c
XVI.ay
XIX.a
XIX.c
Penicillamine
I.a
I.b
I.c
I.d
I.w
I.y
I.bc
II.b
III.a
III.b
III.d
IV.a
IV.c
IV.n
V.a
IX.a
IX.r
X.d
X.e
X.j
X.s
X.ac
XI.t
XV.z
XVII.w